Fiera Capital (Canada)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57M Buy
47,526
+2,108
+5% +$2.15M 0.21% 73
2026
Q1
$41.8M Buy
45,418
+4,122
+10% +$4.18M 0.14% 126
2025
Q4
$44.4M Buy
41,296
+40,740
+7,327% +$39M 0.14% 125
2025
Q3
$424K Sell
556
-24,933
-98% -$18.6M ﹤0.01% 391
2025
Q2
$19.9M Sell
25,489
-5,181
-17% -$4.03M 0.07% 156
2025
Q1
$25.3M Buy
30,670
+3,522
+13% +$2.93M 0.09% 138
2024
Q4
$21M Buy
27,148
+3,976
+17% +$3.29M 0.07% 148
2024
Q3
$20.5M Buy
23,172
+524
+2% +$471K 0.06% 155
2024
Q2
$20.5M Buy
22,648
+5,908
+35% +$4.73M 0.06% 145
2024
Q1
$13M Buy
16,740
+3,424
+26% +$2.44M 0.04% 158
2023
Q4
$7.76M Sell
13,316
-1,635
-11% -$954K 0.02% 180
2023
Q3
$8.03M Sell
14,951
-1,940
-11% -$1,000K 0.03% 169
2023
Q2
$7.92M Sell
16,891
-3,218
-16% -$1.35M 0.02% 174
2023
Q1
$6.91M Buy
20,109
+1,958
+11% +$660K 0.02% 178
2022
Q4
$6.64M Sell
18,151
-946
-5% -$335K 0.02% 180
2022
Q3
$5.9M Buy
19,097
+1,781
+10% +$564K 0.02% 174
2022
Q2
$5.61M Buy
17,316
+1,150
+7% +$345K 0.02% 181
2022
Q1
$4.63M Buy
16,166
+385
+2% +$99.1K 0.01% 216
2021
Q4
$4.36M Buy
15,781
+37
+0.2% +$9.38K 0.01% 218
2021
Q3
$3.64M Sell
15,744
-3,057
-16% -$755K 0.01% 221
2021
Q2
$4.32M Buy
18,801
+3,537
+23% +$710K 0.01% 210
2021
Q1
$2.85M Sell
15,264
-1,227
-7% -$240K 0.01% 245
2020
Q4
$2.78M Buy
16,491
+11,686
+243% +$1.74M 0.01% 313
2020
Q3
$711K Buy
4,805
+2,119
+79% +$328K ﹤0.01% 437
2020
Q2
$441K Sell
2,686
-12,152
-82% -$1.87M ﹤0.01% 494
2020
Q1
$2.06M Sell
14,838
-11,842
-44% -$1.63M 0.01% 314
2019
Q4
$3.51M Buy
+26,680
New +$3.09M 0.01% 274
2019
Q2
Sell
-7,807
Closed -$1.01M 668
2019
Q1
$1.01M Buy
7,807
+1,562
+25% +$190K ﹤0.01% 471
2018
Q4
$723K Sell
6,245
-1,600
-20% -$179K ﹤0.01% 487
2018
Q3
$842K Sell
7,845
-486
-6% -$48.6K ﹤0.01% 502
2018
Q2
$711K Sell
8,331
-684
-8% -$56.2K ﹤0.01% 509
2018
Q1
$697K Sell
9,015
-15,319
-63% -$1.23M ﹤0.01% 481
2017
Q4
$2.06M Sell
24,334
-912
-4% -$77.6K 0.01% 380
2017
Q3
$2.16M Sell
25,246
-15,785
-38% -$1.29M 0.01% 371
2017
Q2
$3.38M Sell
41,031
-17,021
-29% -$1.39M 0.02% 342
2017
Q1
$4.88M Sell
58,052
-1,341
-2% -$107K 0.03% 305
2016
Q4
$4.37M Sell
59,393
-11,333
-16% -$844K 0.02% 360
2016
Q3
$5.68M Sell
70,726
-4,116
-5% -$329K 0.03% 297
2016
Q2
$5.89M Buy
74,842
+39,452
+111% +$2.97M 0.03% 294
2016
Q1
$2.55M Sell
35,390
-1,100
-3% -$83.2K 0.02% 272
2015
Q4
$3.08M Buy
36,490
+850
+2% +$70.5K 0.02% 268
2015
Q3
$2.98M Sell
35,640
-2,400
-6% -$203K 0.02% 264
2015
Q2
$3.18K Sell
38,040
-40,265
-51% -$3.07M 0.02% 301
2015
Q1
$5.69M Sell
78,305
-7,000
-8% -$498K 0.04% 208
2014
Q4
$5.88M Buy
85,305
+17,685
+26% +$1.19M 0.04% 176
2014
Q3
$4.38M Buy
67,620
+41,799
+162% +$2.65M 0.03% 231
2014
Q2
$1.6M Sell
25,821
-38,159
-60% -$2.28M 0.01% 373
2014
Q1
$3.77M Sell
63,980
-41,130
-39% -$2.3M 0.03% 256
2013
Q4
$5.36M Buy
105,110
+74,310
+241% +$3.72M 0.04% 197
2013
Q3
$1.55M Buy
30,800
+400
+1% +$20.9K 0.02% 274
2013
Q2
$1.49M Buy
+30,400
New +$1.65M 0.02% 266

Other funds holding LLY

Fiera Capital (Canada)'s LLY Position: Q2 2026 in Review

Fiera Capital (Canada) increased its Eli Lilly (LLY) stake by 4.6% in Q2 2026, buying an estimated $2.15M and bringing the position to 47,526 shares worth $57M. The position accounts for 0.21% of the portfolio, ranked #73.

Fiera Capital (Canada) first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fiera Capital (Canada) held 47,526 shares of Eli Lilly worth $57M as of Q2 2026.
  • Fiera Capital (Canada) bought 2,108 Eli Lilly shares in Q2 2026, an estimated $2.15M.
  • Eli Lilly made up 0.21% of Fiera Capital (Canada)'s portfolio in Q2 2026, its #73 holding.
  • Fiera Capital (Canada) first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.